ANPEP and melanoma: Furthermore, the results of earlier work demonstrated that the invasion of metastatic fibrosarcoma, melanoma, and renal cell carcinoma in Matrigel could be dose-dependently inhibited by the anti-CD13 monoclonal antibody clone WM15 [89].